Treatment of Patients With Anxiety Disorder (0777-022)

A Double-Blind, Mulitcenter, Placebo-Controlled, Flexible-Dose Replicate Study of MK0777 Gel Extrusion Module (GEM) 3 mg B.I.D. to 8 mg B.I.D. in the Treatment of Outpatients With Generalized Anxiety Disorder

The purpose of the study is to examine the safety and efficacy of MK0777 during treatment for Generalized Anxiety Disorder.

Inclusion Criteria:

• Male and Female patients ages 18 to 70

Exclusion Criteria:

• Women who are breastfeeding or pregnant
• Positive result at prestudy on urine drug screen for illicit drugs
• History of alcohol or drug abuse